CS logo
small CS logo
Hospital del Mar

Barcelona, Spain
General hospital in Barcelona
Passeig Marítim de la Barceloneta, 25, 29, 08003 Barcelona

About Hospital del Mar


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Parc de Salut Mar
39
Pfizer
32
PETHEMA Foundation
24
Spanish Breast Cancer Research Group
21
Celgene
17
Boehringer Ingelheim
14
Gilead Sciences
14
Hoffmann-La Roche
14
Janssen Research & Development, LLC
14
Bayer
12
Incyte Corporation
10
Total Rows: 100

Clinical Trials at Hospital del Mar


During the past decade, Hospital del Mar conducted 400 clinical trials. In the 10-year time frame, 400 clinical trials started and 140 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 150 clinical trials started and 74 clinical trials were completed. i.e. 49.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3939484848485353626258585454343444331313991919222228282020191977Started TrialsCompleted Trails2015201620172018201920202021202220230255075
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
1999-03-01
2007-04-01
Completed
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Secondary Prevention of Small Subcortical Strokes Trial
2003-02-01
2012-04-01
Completed
3,020
Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients With Knee Osteoarthritis
2000-05-01
2002-12-01
Completed
300
"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects
2005-01-01
2007-05-01
Completed
200
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925

Rows per page:

1–100 of 652

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital del Mar" #1 sponsor was "Parc de Salut Mar" with 39 trials, followed by "Pfizer" with 32 trials sponsored, "PETHEMA Foundation" with 24 trials sponsored, "Spanish Breast Cancer Research Group" with 21 trials sponsored and "Celgene" with 21 trials sponsored. Other sponsors include 514 different institutions and companies that sponsored additional 266 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital del Mar" #1 collaborator was "Hospital del Mar" with 17 trials as a collaborator, "Pfizer" with 16 trials as a collaborator, "Hoffmann-La Roche" with 12 trials as a collaborator, "Instituto de Salud Carlos III" with 12 trials as a collaborator and "Germans Trias i Pujol Hospital" with 10 trials as a collaborator. Other collaborators include 488 different institutions and companies that were collaborators in the rest 333 trials.
Created with Highcharts 11.1.0Top Leading SponsorsParc de Salut Mar: 39Parc de Salut Mar: 39Pfizer: 32Pfizer: 32PETHEMA Foundation: 24PETHEMA Foundation: 24Spanish Breast CancerResearch Group: 21Spanish Breast CancerResearch Group: 21Celgene: 17Celgene: 17Boehringer Ingelheim: 14Boehringer Ingelheim: 14Gilead Sciences: 14Gilead Sciences: 14Hoffmann-La Roche: 14Hoffmann-La Roche: 14Janssen Research &Development, LLC: 14Janssen Research &Development, LLC: 14Bayer: 12Bayer: 12

Created with Highcharts 11.1.0Top CollaboratorsHospital del Mar: 17Hospital del Mar: 17Pfizer: 16Pfizer: 16Hoffmann-La Roche: 12Hoffmann-La Roche: 12Instituto de Salud Carlos III: 12Instituto de Salud Carlos III: 12Germans Trias i PujolHospital: 10Germans Trias i PujolHospital: 10Merck Sharp & Dohme LLC: 10Merck Sharp & Dohme LLC: 10AstraZeneca: 9AstraZeneca: 9Bristol-Myers Squibb: 9Bristol-Myers Squibb: 9Eli Lilly and Company: 8Eli Lilly and Company: 8Hospital Clinic of Barcelona: 8Hospital Clinic of Barcelona: 8

Clinical Trials Conditions at Hospital del Mar


According to Clinical.Site data, the most researched conditions in "Hospital del Mar" are "Breast Cancer" (26 trials), "Coronary Artery Disease" (16 trials), "Multiple Myeloma" (13 trials), "HIV Infections" (12 trials) and "Atrial Fibrillation" (11 trials). Many other conditions were trialed in "Hospital del Mar" in a lesser frequency.

Clinical Trials Intervention Types at Hospital del Mar


Most popular intervention types in "Hospital del Mar" are "Drug" (455 trials), "Other" (70 trials), "Device" (44 trials), "Procedure" (42 trials) and "Biological" (34 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (118 trials), "Cyclophosphamide" (15 trials), "Carboplatin" (14 trials), "placebo" (14 trials) and "Capecitabine" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital del Mar


The vast majority of trials in "Hospital del Mar" are 578 trials for "All" genders, 54 trials for "Female" genders and 20 trials for "Male" genders.

Clinical Trials Status at Hospital del Mar


Currently, there are 205 active trials in "Hospital del Mar". 3 are not yet recruiting, 122 are recruiting, 76 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 324 completed trials in Hospital del Mar, 2 suspended trials, and 58 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital del Mar, 38 "Phase 1" clinical trials were conducted, 170 "Phase 2" clinical trials and 222 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 69 trials, and there were also 69 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 222Phase 3: 222Phase 2: 170Phase 2: 170Not Applicable: 69Not Applicable: 69Phase 4: 69Phase 4: 69Phase 1: 38Phase 1: 38Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 324Completed: 324Recruiting: 122Recruiting: 122Active, not recruiting: 76Active, not recruiting: 76Terminated: 58Terminated: 58Unknown status: 58Unknown status: 58Withdrawn: 5Withdrawn: 5Enrolling by invitation: 4Enrolling by invitation: 4Not yet recruiting: 3Not yet recruiting: 3Suspended: 2Suspended: 2